Skip to main content
PMC home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
editorial
. 1982 Apr 24;284(6324):1211–1212. doi: 10.1136/bmj.284.6324.1211-a

Therapeutic potential of cannabinoids.

D N Bateman, M D Rawlins
PMCID: PMC1498053  PMID: 6803904

Full text

PDF
1211

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Colls B. M. Cannabis and cancer chemotherapy. Lancet. 1980 May 31;1(8179):1187–1188. doi: 10.1016/s0140-6736(80)91642-6. [DOI] [PubMed] [Google Scholar]
  2. Colls B. M., Ferry D. G., Gray A. J., Harvey V. J., McQueen E. G. The antiemetic activity of tetrahydrocannabinol versus metoclopramide and thiethylperazine in patients undergoing cancer chemotherapy. N Z Med J. 1980 Jun 25;91(662):449–451. [PubMed] [Google Scholar]
  3. Ekert H., Waters K. D., Jurk I. H., Mobilia J., Loughnan P. Amelioration of cancer chemotherapy-induced nausea and vomiting by delta-9-tetrahydrocannabinol. Med J Aust. 1979 Dec 15;2(12):657–659. [PubMed] [Google Scholar]
  4. Frytak S., Moertel C. G., O'Fallon J. R., Rubin J., Creagan E. T., O'Connell M. J., Schutt A. J., Schwartau N. W. Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo. Ann Intern Med. 1979 Dec;91(6):825–830. doi: 10.7326/0003-4819-91-6-825. [DOI] [PubMed] [Google Scholar]
  5. Gralla R. J., Itri L. M., Pisko S. E., Squillante A. E., Kelsen D. P., Braun D. W., Jr, Bordin L. A., Braun T. J., Young C. W. Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. N Engl J Med. 1981 Oct 15;305(16):905–909. doi: 10.1056/NEJM198110153051601. [DOI] [PubMed] [Google Scholar]
  6. Hartley J. P., Nogrady S. G., Seaton A. Bronchodilator effect of delta1-tetrahydrocannabinol. Br J Clin Pharmacol. 1978 Jun;5(6):523–525. doi: 10.1111/j.1365-2125.1978.tb01667.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Herman T. S., Einhorn L. H., Jones S. E., Nagy C., Chester A. B., Dean J. C., Furnas B., Williams S. D., Leigh S. A., Dorr R. T. Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy. N Engl J Med. 1979 Jun 7;300(23):1295–1297. doi: 10.1056/NEJM197906073002302. [DOI] [PubMed] [Google Scholar]
  8. Lucas V. S., Jr, Laszlo J. delta 9-Tetrahydrocannabinol for refractory vomiting induced by cancer chemotherapy. JAMA. 1980 Mar 28;243(12):1241–1243. [PubMed] [Google Scholar]
  9. Noyes R., Jr, Brunk S. F., Avery D. A., Canter A. C. The analgesic properties of delta-9-tetrahydrocannabinol and codeine. Clin Pharmacol Ther. 1975 Jul;18(1):84–89. doi: 10.1002/cpt197518184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Orr L. E., McKernan J. F., Bloome B. Antiemetic effect of tetrahydrocannabinol. Compared with placebo and prochlorperazine in chemotherapy-associated nausea and emesis. Arch Intern Med. 1980 Nov;140(11):1431–1433. doi: 10.1001/archinte.140.11.1431. [DOI] [PubMed] [Google Scholar]
  11. Poster D. S., Penta J. S., Bruno S., Macdonald J. S. delta 9-tetrahydrocannabinol in clinical oncology. JAMA. 1981 May 22;245(20):2047–2051. [PubMed] [Google Scholar]
  12. Sallan S. E., Cronin C., Zelen M., Zinberg N. E. Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine. N Engl J Med. 1980 Jan 17;302(3):135–138. doi: 10.1056/NEJM198001173020302. [DOI] [PubMed] [Google Scholar]
  13. Uppal R., Garg S. K., Sharma P. R., Varma V. K., Chaudhury R. R. Antipyrine kinetics in cannabis smokers. Br J Clin Pharmacol. 1981 May;11(5):522–523. doi: 10.1111/j.1365-2125.1981.tb01162.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES